We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

RCT of the Efficacy of the Ketogenic Diet in the Treatment of Epilepsy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00564915
First Posted: November 29, 2007
Last Update Posted: November 29, 2007
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Institute of Child Health
  Purpose
A study of the efficacy and tolerability of two different ketogenic diets in children with drug resistant epilepsy; children resistant to at least two drugs randomised to reveive diet after baseline or after further 3m control period; in addition randomised to either MCT or classical ketogenic diet.

Condition Intervention Phase
Epilepsy Dietary Supplement: Ketogenic diet Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: RCT of the Efficacy of the Ketogenic Diet in the Treatment of Epilepsy

Resource links provided by NLM:


Further study details as provided by Institute of Child Health:

Primary Outcome Measures:
  • Change in seizure frequency [ Time Frame: 3 months ]

Secondary Outcome Measures:
  • Tolerability and assessment of ketosis and growth [ Time Frame: 3 months ]

Enrollment: 145
Study Start Date: December 2001
Study Completion Date: July 2006
Intervention Details:
    Dietary Supplement: Ketogenic diet
    Ketogenic diet
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   2 Years to 16 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of epilepsy for at least 2 years, resistant to at least two AEDs, at least 7 seizures/week
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00564915


Locations
United Kingdom
Institute of Child Health, The Wolfson Centre
London, United Kingdom, WC1N 1EH
Sponsors and Collaborators
Institute of Child Health
Investigators
Principal Investigator: Helen Cross, Professor UCL Institute of Child Health
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Tracy Assari, Institute of Child Health
ClinicalTrials.gov Identifier: NCT00564915     History of Changes
Other Study ID Numbers: 98NR04
First Submitted: November 28, 2007
First Posted: November 29, 2007
Last Update Posted: November 29, 2007
Last Verified: November 2007

Keywords provided by Institute of Child Health:
Epilepsy

Additional relevant MeSH terms:
Epilepsy
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases